✦ LIBER ✦

Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosis

✍ Scribed by DeAngelo, Daniel J.; Mesa, Ruben A.; Fiskus, Warren; Tefferi, Ayalew; Paley, Carole; Wadleigh, Martha; Ritchie, Ellen K.; Snyder, David S.; Begna, Kebede; Ganguly, Siddhartha; Ondovik, Michael S.; Rine, Jessica; Bhalla, Kapil N.

Book ID: 120424393
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 336 KB
Volume: 162
Category: Article
ISSN: 0007-1048
DOI: 10.1111/bjh.12384

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of tipifarnib in myelof

A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia

✍ Mesa, R A; Camoriano, J K; Geyer, S M; Wu, W; Kaufmann, S H; Rivera, C E; Erlich 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 139 KB

Phase II Study of Sunitinib in Patients

Phase II Study of Sunitinib in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis

✍ Effrosyni Apostolidou; Hagop Kantarjian; Deborah Thomas; Ian Burger; Gautam Bort 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 108 KB

A phase II study of 5-azacitidine for pa

A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis

✍ Tong, W; Kantarjian, H; Thomas, D; Ravandi, F; Kornblau, S; Manshouri, T; Cortes 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 132 KB